Tissue Regenix Group PLC (AIM:TRX, OTC:TSSNF) said it has inked an exclusive distribution deal for its OrthoPure XT product in Germany.
The artificial ligament will be sold by Hamburg-based 2med, a specialist in surgical and ortho-biological treatments.
While the focus initially will be Germany, there is scope to expand the muli-year deal to further territories,
"Following the success of our partnership with Geistlich Biomaterials Italia, which we announced in March 2022, we are pleased to have signed this distribution agreement with 2med for Germany,” said Tissue Regenix chief executive Daniel Lee in a statement.
“2med's work with doctors and patients, to offer advanced treatments and minimise rehabilitation times, are aligned with this innovative product and has made 2med one of the leading specialist dealers in Germany," he added.